Myocardial Infarction

 

Tips&Tools

About
 Daily News from Top Searches
Popular Searches
Tips on Searching
SearchMedica for IPhone
Go To SearchMedica
Sign Up For Our Newsletter



FeaturedArticles

May 7, 2013
Rivaroxaban Reduces Thrombotic Events Post-MI
Small, twice-daily doses of rivaroxaban may offer an effective strategy to reduce thrombotic events in patients following ST-elevation myocardial infarction (STEMI). More »
February 19, 2013
CT Angiography Aids in Predicting Heart Attack Risk
CCTA is effective for determining heart attack risk in patients with suspected coronary artery disease — even if there are no treatable risk factors. More »
January 28, 2013
Myocardial Infarction Risk in Women Reduced With Intake of Berries
Blueberries and strawberries contain high concentrations of anthocyanins, a flavonoid shown to help lower blood pressure and improve endothelial function. More »
January 17, 2013
Yet More Evidence Links High Vitamin D to Reduced CV Risk
Two new studies from Europe strengthen the association between vitamin D levels and risk of cardiovascular disease. More »
January 16, 2013
How Schizophrenia Patients Ease Burdens With Smoking
A 10-year-study shows how common the smoking habit is among people who have schizophrenia, and a different study clarifies one of the consequences. More »
Showing 1 - 5 of 61 results.
Page of 13
First Previous Last

PubMed

Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia.
pubmed.gov - 2/12/13
Peginesatide in patients with anemia undergoing hemodialysis.
pubmed.gov - 1/23/13
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.
pubmed.gov - 1/22/13
Relationship between serum level of high-sensitive C-reactive protein and extension of myocardial involvement in patients with acute myocardial infarction.
pubmed.gov - 1/20/13
Cardioprotection: chances and challenges of its translation to the clinic.
pubmed.gov - 1/11/13
More Results


TopicIndex

FromPhysiciansPractice

Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

PatientResources

Myocardial infarction
ghr.nlm.nih.gov - 3/18/13
Heart Attack: MedlinePlus
www.nlm.nih.gov - 3/15/13
Systematic Review of ECG-based Technologies for Evaluating Patients With Acute Coronary Syndrome
www.ahrq.gov - 11/1/12

Result Pages: 1 2 3 4 5 6 7 8 Next


SearchMedicaNews


Helping NSCLC Patients to Fight Fatigue with Fitness
May 17, 2013

A new program to fight post-thoractoromy fatigue, and insights into how late-stage lung cancer patients perceive the advice to remain active.

Prolonged Fatigue Reflects Mood Disorders in Adolescents
May 16, 2013

Clinicians should pay more attention to the debilitating symptoms of adolescent fatigue, say commentators responding to a survey that shows prolonged fatigue may indicate severe depression or anxiety.

Cultivating New Treatments in Follicular Lymphoma
May 15, 2013

Intensified therapy including CNS prophylaxis proves promising for reducing or delaying side effects in malignant B-cell lymphoma.